We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Toshiba Announces PET Distribution Agreement

By HospiMedica staff writers
Posted on 11 Nov 2003
Under the terms of a distribution agreement, Toshiba Medical Systems Corp. (Tokyo, Japan; www.toshiba.com) will distribute in Japan certain positron emission tomography (PET) products of CPS Innovations, the trade name for CTI Systems, Inc., a joint venture of CTI Molecular Imaging, Inc. (Knoxville, TN, USA) and Siemens Medical Solutions USA, Inc. (Malvern, PA, USA).

The PET systems to be distributed by Toshiba will feature the LSO FastPET technology of CPS and will be supported by Toshiba's customer service force. This technology allows for much faster scanning times than predecessor technologies and is well suited for clinical applications in Japan, because its physical characteristics maximize image quality at the lowest possible dose level.

"We will be able to provide our customers in Japan with the highest diagnostic performance by combining the CPS PET systems and our specialized applications technology cultivated with our SPECT technology,” said Kenichiro Katsumata, senior vice president, Toshiba Medical Systems Corp.





Related Links:
Toshiba Med. Systems
CTI
Siemens Med. Solutions USA
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Multi-Chamber Washer-Disinfector
WD 390
New
Medical Adhesive
MED 5570U

Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more